Scientific article
English

Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study

Published in

The Journal of infectious diseases, vol. 208, no. 9, p. 1454-1458

Publication date

2013

Abstract

Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients worldwide. It is unclear whether HIV-related outcomes are affected by HBV coinfection. We compared virological suppression and immunological recovery during antiretroviral therapy (ART) of patients of different HBV serological status in the Swiss HIV Cohort Study. CD4 cell recovery during ART was significantly impaired in hepatitis B surface antigen-positive patients and in those with anti-hepatitis B core antigen alone compared with HBV-uninfected patients, despite similar virological efficacy of ART. CD4 increase in patients with resolved HBV infection was similar to that in HBV-uninfected individuals.

UNIGE research groups

Citation (ISO format)

WANDELER, Gilles et al. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. In: The Journal of infectious diseases, 2013, vol. 208, n° 9, p. 1454–1458. doi: 10.1093/infdis/jit351

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0022-1899
674views
0downloads

Technical informations

Creation

28/11/2013 11:15:00

First validation

28/11/2013 11:15:00

Update

14/03/2023 20:56:26

Status update

14/03/2023 20:56:25

Last indexation

30/10/2024 16:09:45
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated